Synthesis, screening and docking of fused pyrano[3,2- d ]pyrimidine derivatives as xanthine oxidase inhibitor-Reference-Cited by-同舟云学术

Synthesis, screening and docking of fused pyrano[3,2- d ]pyrimidine derivatives as xanthine oxidase inhibitor

Published:2017-05 Issue: Volume:131 Page:14-28
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Kaur Manroopraj,Kaur Amandeep,Mankotia Suhani,Singh Harbinder,Singh Arshdeep,Singh Jatinder Vir,Gupta Manish Kumar,Sharma Sahil,Nepali Kunal,Bedi Preet Mohinder Singh

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference36 articles.

1. A rational approach for the design and synthesis of 1-acetyl-3,5-diaryl-4,5-dihydro(1H)pyrazoles as a new class of potential non-purine xanthine oxidase inhibitors

2. Synthesis and evaluation of naphthoflavones as a new class of non purine xanthine oxidase inhibitors

3. Reappraisal of the pathogenesis and consequences of hyperuricemia in hypertension, cardiovascular disease, and renal disease

4. Free Radicals in the Physiological Control of Cell Function

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of 4‐(isopentyloxy)‐3‐nitrobenzamide derivatives as xanthine oxidase inhibitors through a non‐anthraquinone exploration;Archiv der Pharmazie;2024-07-04

2. Recent developments in synthetic strategies and pharmacological outcomes of synthetic xanthine oxidase inhibitors: A comprehensive review;Journal of Heterocyclic Chemistry;2024-03-05

3. Triazole derivatives as potential xanthine oxidase inhibitors: Design, enzyme inhibition potential, and docking studies;Archiv der Pharmazie;2024-01-09

4. Heterocyclic compounds as xanthine oxidase inhibitors for the management of hyperuricemia: synthetic strategies, structure–activity relationship and molecular docking studies (2018–2024);RSC Medicinal Chemistry;2024

5. Prenylated flavonoids from Dalea genus as xanthine oxidase inhibitors: In vitro bioactivity evaluation and molecular docking studies;Results in Chemistry;2023-12